MedPath

Bioequivalence study of Dutasteride/tamsulosin 0.5/0.4 mg capsule

Not Applicable
Recruiting
Conditions
This study is performed on healthy volunteers and drug concentration in plasma is determined..
Registration Number
IRCT20200105046010N91
Lead Sponsor
Tasnim company
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
24
Inclusion Criteria

General Health (Liver, Heart, and Kidney)
Body Mass Index (18-28)
Informed consent
Age (18-55 years old)

Exclusion Criteria

Smoking
History of cardiovascular disease
History of liver and kidney disease
Alcoholism and Narcoticism
History of allergy to Dutasteride and tamsulosin

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.